Early onset, maintenance of effect, and day-/night-time findings following fezolinetant treatment for moderate to severe vasomotor symptoms associated with menopause: A pooled phase 3 analysis

Authors

Petra Stute (ORCID: https://orcid.org/0000-0002-5591-1552)
Wendy Wolfman (ORCID: https://orcid.org/0000-0001-8996-7303)
Rebecca C. Thurston (ORCID: https://orcid.org/0000-0001-6580-1202)
Genevieve Neal-Perry
Faith D. Ottery (ORCID: https://orcid.org/0000-0002-6295-5166)
Xi Wu (ORCID: https://orcid.org/0000-0001-6572-4155)
Marci English (ORCID: https://orcid.org/0000-0002-3600-5677)
Marla Shapiro C M (ORCID: https://orcid.org/0000-0002-4523-2169)

Institutions

University of North Carolina at Chapel Hill (US)
University of Pittsburgh (US)
University of Toronto (CA)
University Hospital of Bern (CH)
UPMC Health System (US)
Sinai Health System (CA)
University of Pittsburgh Medical Center (US)
Astellas Pharma (United States) (US)

Publication Details

Journal: Maturitas
Published: 2025-10-04
DOI: https://doi.org/10.1016/j.maturitas.2025.108740
Primary Topic: Menopause: Health Impacts and Treatments
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Early onset, maintenance of effect, and day-/night-time findings following fezolinetant treatment for moderate to severe vasomotor symptoms associated with menopause: A pooled phase 3 analysis

Petra Stute, Wendy Wolfman, Rebecca C. Thurston, Genevieve Neal-Perry et al.

Oct 4, 2025

Maturitas

Menopause: Health Impacts and Treatments

article

Early onset, maintenance of effect, and day-/night-time findings following fezolinetant treatment for moderate to severe vasomotor symptoms associated with menopause: A pooled phase 3 analysis

Petra Stute, Wendy Wolfman, Rebecca C. Thurston, Genevieve Neal-Perry, Faith D. Ottery, Xi Wu, Marci English, Marla Shapiro C M

October 4, 2025article en

Abstract

No abstract available for this paper.

MaturitasVol. 203

University of North Carolina at Chapel Hill (US), University of Pittsburgh (US), University of Toronto (CA), University Hospital of Bern (CH), UPMC Health System (US), Sinai Health System (CA), University of Pittsburgh Medical Center (US), Astellas Pharma (United States) (US)

Openalex Percentile: Top 63%

Menopause: Health Impacts and Treatments

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Early onset, maintenance of effect, and day-/night-time findings following fezolinetant treatment for moderate to severe vasomotor symptoms associated with menopause: A pooled phase 3 analysis — Petra Stute, Wendy Wolfman, et al. · Maturitas (2025) | TGRS Research Map | TGRS